Disc Medicine, Inc.

As of May 29, 2025, Disc Medicine, Inc. shows a mildly bearish trend due to daily moving averages and monthly RSI indicating bearish conditions, despite some mildly bullish signals from weekly indicators, suggesting caution in the current market environment.

Disc Medicine, Inc. is a blank check company targeting mergers in the biotechnology sector, currently reporting a net loss of $34 million and a market cap of approximately $1.73 billion. It has no dividend yield and negative return on equity.

As of Jun 18, Disc Medicine, Inc. has a market capitalization of 1,733.45 million and reported net sales of 0.00 million with a net profit of -116.50 million over the last four quarters. As of Dec 24, the company has shareholder's funds of 443.59 million and total assets of 496.77 million.